Novo Nordisk A/S ( NOVO-B.CO) - Key Metrics
NOVO-B.CO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | DKK17.81 | DKK6.05 | DKK1.71 | -DKK2.43 |
| 2025Q3 | DKK16.86 | DKK4.50 | DKK10.37 | DKK7.31 |
| 2025Q2 | DKK17.28 | DKK5.96 | DKK9.17 | DKK5.51 |
| 2025Q1 | DKK17.59 | DKK6.54 | DKK5.54 | DKK2.25 |
NOVO-B.CO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 13.44 |
| 2025Q3 | 83.29% | 19.15 |
| 2025Q2 | 0.66% | 18.44 |
| 2025Q1 | 121.49% | 17.96 |
NOVO-B.CO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.17% | ? |
| 2025Q4 | -2.51% | ? |
| 2025Q3 | 2.00% | 1.09% |
| 2025Q2 | 1.25% | 0.01% |
| 2025Q1 | 0.48% | 1.69% |
NOVO-B.CO
Price: DKK287.25
Dividend Yield: 3.90%
Forward Dividend Yield: 5.54%
Payout Ratio: 34.79%
Dividend Per Share: 15.90 DKK
Earnings Per Share: 27.42 DKK
P/E Ratio: 11.01
Exchange: CPH
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Volume: 2.2 million
Market Capitalization: 1.3 trillion
Average Dividend Frequency: 2
Years Paying Dividends: 27
DGR3: 8.84%
DGR5: 9.95%
DGR10: 13.03%
DGR20: 11.63%